Rhea-AI Summary
Genomma Lab Internacional, S.A.B. de C.V. reported its financial results for the fourth quarter and full year ended December 31, 2022. Key highlights include a net sales increase of 8.9% year-on-year, reaching Ps. 16.86 billion, and a gross profit rise of 6.6%, totaling Ps. 10.20 billion. The operating income grew by 7.1%, amounting to Ps. 3.26 billion, with an EBITDA increase of 8.1% and a margin of 20.6%. However, the fourth quarter showed a decline in gross profit margin to 57.1% from 63.0% year-over-year. The conference call for Q4 results is scheduled for February 23, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.75%
Tags
FAQ
What is the current stock price of Genomma Lab Intl SAB (GNMLF)?
Genomma Lab Intl SAB (GNMLF) last closed at $0.8350.
What is the market cap of Genomma Lab Intl SAB (GNMLF)?
The market cap of Genomma Lab Intl SAB (GNMLF) is approximately $816.4M.